Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Two 6-Month Leuprolide Formulations in Prostate Cancer
NCT00626431Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2008
- Primary completion
- Aug 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in prostate cancer (PCa), sponsored by Abbott Laboratories. Started Feb 2008; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00626431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626431.